The global Vitreous Tamponades Market is estimated to be valued at US$ 76.0 Mn or Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Vitreous tamponades are surgical products made from gases, liquids and sometimes silicone oils that are injected into the eye during retinal detachment surgery to cushion and support the retina while it heals back into place against the underlying layers of tissue. They act as a temporary intraocular bandage or tamponade to flatten the retinal detachment.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/vitreous-tamponades-market-1193
Market key trends:
One of the key trends in the vitreous tamponades market is the growing preference for silicone oil tamponades over gas tamponades. Silicone oil tamponades have certain advantages over gas tamponades such as longer duration of effect, maintaining intraocular pressure and fewer postoperative positioning restrictions. Although silicone oils require subsequent surgical removal compared to gases which are absorbed naturally, they provide superior and longer lasting tamponade effect which is driving increasing adoption.
SWOT Analysis
Strength: The vitreous tamponades market is witnessing consistent growth due to the increasing prevalence of retinal detachment and macular hole conditions globally. The rising demand for tamponades such as silicone oil and gas tamponades for surgical use is fueling market growth.
Weakness: However, recurrence of retinal detachment post-surgery in some cases and high costs associated with vitreous tamponades may restrain market growth.
Opportunity: Untapped emerging markets in Asia Pacific and Latin America offer lucrative growth opportunities for players. In addition, ongoing R&D for development of advanced tamponades will further support the market expansion.
Threats: Strict regulations pertaining to approval and manufacturing of vitreous tamponades can impede market revenues. High preference for alternative treatment options also poses threats to market growth.
Key Takeaways
The global vitreous tamponades market size is expected to witness high growth, exhibiting a CAGR of 2.5% over the forecast period 2023 to 2030, driven by increasing prevalence of retinal disorders globally.
Regional analysis:
North America is expected to dominate the global market throughout the forecast period. This is attributed to the presence of major players, high healthcare spending, and rising prevalence of macular degeneration in the region. Asia Pacific is anticipated to witness fastest growth during the forecast timeline due to rising geriatric population, improved access to healthcare, and increasing focus of international players in emerging countries.
Key players:
Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Major players are focusing on new product approvals and geographic expansion to strengthen their market position.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it